Wordt geladen...
Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation
Novel oral anticoagulants, including dabigatran, rivaroxaban, and apixaban, represent new options for preventing stroke in patients with atrial fibrillation, as shown by the results from large, randomized phase III trials. Because of their greater specificity, rapid onset of action, and predictable...
Bewaard in:
| Gepubliceerd in: | Clin Cardiol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wiley Periodicals, Inc.
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6649642/ https://ncbi.nlm.nih.gov/pubmed/24254991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22204 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|